What is the recommended CT (Computed Tomography) scan order for a patient with a suspected adrenal myelolipoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended CT Scan Order for Suspected Adrenal Myelolipoma

For a patient with suspected adrenal myelolipoma, a non-contrast CT scan of the abdomen should be ordered as the initial imaging study, as it can reliably identify the characteristic macroscopic fat within the lesion. 1, 2

Diagnostic Imaging Algorithm

  1. First-line imaging:

    • Non-contrast CT abdomen
    • Look for: Characteristic fat density (negative Hounsfield units, HU < 10)
    • Macroscopic fat within the lesion is pathognomonic for myelolipoma 2
  2. If initial non-contrast CT is indeterminate:

    • Proceed with contrast-enhanced washout CT
    • Parameters to assess: >60% washout at 15 minutes suggests benign lesion 1, 2
  3. Alternative second-line imaging if needed:

    • Chemical shift MRI (if CT findings are equivocal)
    • Look for: Signal intensity loss in opposed-phase images 1, 2

Key CT Findings in Adrenal Myelolipoma

  • Presence of macroscopic fat (negative HU values) is diagnostic 3
  • May have heterogeneous appearance if containing varying amounts of myeloid tissue 4
  • Size can range from small to large (reported cases from 2-9 cm) 3
  • Predominantly right-sided in some case series, though can occur bilaterally 3, 5

Important Considerations

  • Precontrast images are essential to avoid diagnostic errors 3
  • Myelolipomas composed primarily of myeloid tissue may not show the typical fat density and can appear more heterogeneous 3, 4
  • CT is superior to ultrasound for definitive diagnosis, as ultrasound findings can be variable (hyperechoic in fat-predominant lesions, hypoechoic in myeloid-predominant lesions) 3, 4

Management Based on Imaging Findings

  • Myelolipomas <4 cm that contain macroscopic fat on initial imaging require no further follow-up imaging or functional testing 1, 2
  • Myelolipomas ≥4 cm but radiologically benign should undergo repeat imaging in 6-12 months 1, 2
  • Consider adrenalectomy if growth is >5 mm/year after repeating functional workup 1, 2
  • No further imaging follow-up is required if growth is <3 mm/year on follow-up imaging 1
  • Surgical removal may be indicated for symptomatic lesions or those exceeding 7 cm 6

Common Pitfalls to Avoid

  • Failing to obtain precontrast images, which are essential for identifying fat density 3
  • Misdiagnosing myeloid-predominant myelolipomas that may not show typical fat density 4
  • Unnecessary follow-up imaging for small (<4 cm) myelolipomas with characteristic fat density 1, 2
  • Overlooking the need to exclude functional adrenal disorders through appropriate hormonal evaluation, even though myelolipomas are typically non-functioning 2, 7

By following this approach, the diagnosis of adrenal myelolipoma can be established with high confidence, avoiding unnecessary additional testing or interventions for this benign condition.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Adrenal Myelolipoma Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Myelolipoma of the adrenal gland: sonographic and CT features.

AJR. American journal of roentgenology, 1988

Research

Adrenal myelolipoma: from tumorigenesis to management.

The Pan African medical journal, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.